1. Revealing binding selectivity of ligands toward murine double minute 2 and murine double minute X based on molecular dynamics simulations and binding free energy calculations
- Author
-
Shaolong Zhang, Kai Sui, Shuhua Shi, Qinggang Zhang, Yanzi Lei, and Weizhe Liu
- Subjects
MDMX ,Binding free energy ,030303 biophysics ,Enthalpy ,Cell Cycle Proteins ,Molecular Dynamics Simulation ,Ligands ,Molecular mechanics ,03 medical and health sciences ,Molecular dynamics ,Mice ,Structural Biology ,Proto-Oncogene Proteins ,Animals ,Molecular Biology ,Binding selectivity ,0303 health sciences ,Chemistry ,Nuclear Proteins ,Proto-Oncogene Proteins c-mdm2 ,General Medicine ,Highly selective ,Biophysics ,Free energies ,Tumor Suppressor Protein p53 ,Protein Binding - Abstract
It is well known that the interactions of p53 with murine double minute 2 and murine double minute X, namely MDM2 and MDMX, have been significant targets of efficient anti-cancer drug design. In this study, molecular dynamics (MD) simulations, principal component (PC) analysis and binding free energy calculations are combined to recognize binding selectivity of three ligands to MDM2 and MDMX. The binding free energies were estimated by using molecular mechanics generalized Born surface area (MM-GBSA) method and the obtained results display that the increase in the binding enthalpy of three ligands to MDM2 relative to MDMX mainly drives the binding selectivity of them toward MDM2 and MDMX. The information obtained from PC analysis shows that the associations of ligands exert important impacts on internal dynamics of MDM2 and MDMX. Meanwhile, the calculations of residue-based free energy decomposition not only identify the hot interaction spots of ligands with MDM2 and MDMX, but also show the residues (L54, M53), (Y67, Y66), (V93, V92), (H96, P95), (I99, I98) and (Y100, Y99) in (MDM2, MDMX) are responsible for most contributions to the binding selectivity of three ligands toward MDM2 and MDMX. It is believed that this work can provide useful information for design of highly selective and dual inhibitors targeting MDM2 and MDMX.Communicated by Ramaswamy H. Sarma.
- Published
- 2019